HK StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nonprofit Pharmaceutical Companies

632.580

+5.5010.88%

Number of Gainers:19

Number of Losers:12

Number of Flat:3

PE:- -

High:646.383

Open:626.947

Low:621.207

Close:627.079

Volume:112.11M

Turnover:2.21B

Market Cap:388.84B

Float Cap:348.26B

Loading ...

Top Private Equity Funds Favor Tech and Healthcare, Financials Get Heavy Allocation

HK Stock Connect Shareholding Changes | November 12

LAEKNA-B (02105) Enters Exclusive Licensing Agreement with Qilu Pharma for LAE 002 (Afuresertib) in China

Hong Kong Stock Concept Tracking | China's First Brain-Computer Interface Enters Regulatory Fast Track, Accelerating Commercialization (With Concept Stocks)

BRIEF-Venus Medtech Hangzhou Agrees To Sell Property For RMB374.6 Mln

VENUS MEDTECH-B (02500) Plans to Sell Hangzhou Property for Approximately RMB375 Million

Venus Medtech Hangzhou - Agrees to Sell Property for RMB374.6 Mln

THOMSON REUTERS

BioDlink International Swings to Nine-Month Loss

MT Newswires Live

Pharma Giant AstraZeneca Hits Record High, Cementing Top Spot in UK Market

CARSGEN-B (02171) Repurchases 245,000 Shares for HK$4.047 Million on November 11

CSPC Pharma's HER2 Antibody Application Accepted, CR Sanjiu Secures Rare Disease Drug, Domestic CAR-T Goes Global for Over $860M

HBM HOLDINGS-B (02142) Repurchases 150,000 Shares for HK$1.978 Million on November 11

HBM Holdings Files HKEX Disclosure on Buyback of 150,000 Shares at HKD 13.27 Each

Audit Storm Hits Public Hospitals: Irregularities in Procurement and Operations Exposed

Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$16.4 per Share

BIODLINK-B (01875) Reports Revenue of RMB622 Million in First Three Quarters

JACOBIO-B (01167) Repurchases 72,000 Shares for HK$482,300 on November 11

Jacobio Pharmaceuticals Repurchases 72,000 Shares at HK$6.70 Each, Files Disclosure Return to HKEX

TOT BIOPHARM International 9M Revenue RMB 621.67 Million

THOMSON REUTERS

Zai Lab (09688) Grants Stock Options and Restricted Share Units

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/BK1574/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1574","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","market":"HK","secType":"PLATE","nameCN":"Nonprofit Pharmaceutical Companies","latestPrice":632.5798,"timestamp":1763102154270,"preClose":627.0787,"halted":0,"volume":112111213,"delay":0,"changeRate":0.008773,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":5.501099,"latestTime":"11-14 14:35:54","open":626.9466,"high":646.38324,"low":621.20734,"amount":2207106833,"amplitude":0.040148,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1763107800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1763083800000,1763092800000],[1763096400000,1763107200000]],"pbRate":5.349541,"peRate":-44.158668,"turnoverRate":0.004154,"increases":19,"decrements":12,"flats":2,"marketCap":388838375808,"floatMarketCap":348260139824},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1574\",,,,,undefined,":{"symbol":"BK1574","high":646.38324,"amplitude":0.040148,"preClose":627.0787,"low":621.20734,"pbRate":"5.349541","latestPrice":632.5798,"volume":112111213,"delay":0,"open":626.9466,"prevYearClose":331.1933,"prevWeekClose":587.579,"prevMonthClose":618.706,"prevQuarterClose":752.859,"fiveDayClose":587.579,"twentyDayClose":673.448,"sixtyDayClose":830.772,"secType":"PLATE","market":"HK","turnoverRate":0.004154,"peRate":-44.158668,"marketCap":388838375808,"floatMarketCap":348260139824,"timestamp":1763102154270,"nameCN":"Nonprofit Pharmaceutical Companies"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1574\",,,,undefined,":{"bkCode":"BK1574","up":19,"down":12,"flat":3},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1574\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1118604871","title":"Top Private Equity Funds Favor Tech and Healthcare, Financials Get Heavy Allocation","url":"https://stock-news.laohu8.com/highlight/detail?id=1118604871","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118604871?lang=en_us&edition=fundamental","pubTime":"2025-11-12 09:11","pubTimestamp":1762909918,"startTime":"0","endTime":"0","summary":"Recent monthly reports from multiple private equity funds reveal the latest investment strategies of major players in the market. As key participants, the moves of billion-dollar private equity funds...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","159938","09939","159940","BK1515"],"gpt_icon":0},{"id":"1181014719","title":"HK Stock Connect Shareholding Changes | November 12","url":"https://stock-news.laohu8.com/highlight/detail?id=1181014719","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181014719?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:38","pubTimestamp":1762907908,"startTime":"0","endTime":"0","summary":"As of November 11, 2025, data shows that HAO TIAN INTL (01341), REPT BATTERO (00666), and CTG DUTY-FREE (01880) recorded the largest increases in Stock Connect shareholding ratios, rising by 1.72%,...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02465","02828","BK1147","BK1129","BK1590","BK1587","02631","BK1521","00874","LU0348825331.USD","BK1574","BK1500","BK1555","03931","BK1228","BK1567","LU1983299162.USD","BK1170","BK1515","BK1522","BK1197","03759","01071","BK1588","BK1594","BK1610","LU0326950275.SGD","BK1518","BK1556","HK0000252152.HKD","02402","IE00BZ08YT58.USD","LU1720050803.USD","BK1596","LU0417516738.SGD","BK1530","BK1240","06616","BK1161","02562","BK1148","IE00BZ08YR35.GBP","LU0417516902.SGD","BK1523","LU0052750758.USD","02533","BK1236","00666","09688","BK1511","LU1969619763.USD","00763","03800","BK1564","00902","03678","02382","BK1109","LU0708995583.HKD","BK1568","MCHmain","LU1794554557.SGD","BK1526","00568","02865","02837","BK1205","01773","00956","09885","SG9999003461.SGD","BK1171","02648","LU0588546209.SGD","BK1191","02162","BK1607","00119","BK1116","BK1513","IE00B29SXG58.USD","LU2543165471.USD","BK1503","01053","01709","BK1237","BK1582","BK1576","LU1831875114.USD","BK1554","BK1613","00095","BK1125","BK1141","00968","00525","00187","00189","BK1219","BK1558","01347","06865","BK1614","BK1505","01072","BK1589","06682","BK1546","LU2328871848.SGD","BK1608","HK0000252160.HKD","06869","BK1529","09995","IE0034224299.USD","BK1138","BK1149","BK1224","03347","BK1110","BK1504","BK1144","BK1516","LU1211504680.USD","BK1560","01877","01880","02587","03866","BK1163","02013","02255","09606","LU0307460666.USD","02068","BK1183","06680","LU2488822045.USD","SG9999014674.SGD","BK1169","BK1235","BK1241","SG9999006597.SGD","02050","09696","IE00BZ08YS42.EUR","01282","02727","BK1202","BK1225","HK0000500386.USD","06613","BK1583","06955","02208","LU0348735423.USD","BK1506","BK1606","BK1166","LU0320764599.SGD","01341"],"gpt_icon":1},{"id":"1195708215","title":"LAEKNA-B (02105) Enters Exclusive Licensing Agreement with Qilu Pharma for LAE 002 (Afuresertib) in China","url":"https://stock-news.laohu8.com/highlight/detail?id=1195708215","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195708215?lang=en_us&edition=fundamental","pubTime":"2025-11-12 08:28","pubTimestamp":1762907314,"startTime":"0","endTime":"0","summary":"LAEKNA-B (02105) announced on November 12, 2025, that the group has entered into an exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (Qilu Pharma). Under the terms of the agreement,...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02105","01477","BK1191","BK1161","BK1574"],"gpt_icon":0},{"id":"1193726476","title":"Hong Kong Stock Concept Tracking | China's First Brain-Computer Interface Enters Regulatory Fast Track, Accelerating Commercialization (With Concept Stocks)","url":"https://stock-news.laohu8.com/highlight/detail?id=1193726476","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193726476?lang=en_us&edition=fundamental","pubTime":"2025-11-12 07:20","pubTimestamp":1762903225,"startTime":"0","endTime":"0","summary":"China's brain-computer interface (BCI) sector has received another boost. On November 11, Shanghai-based Step Medical Technology's self-developed \"Implantable Wireless Brain-Computer Interface...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996","00553","02172","BK1100","BK1149","06609","BK1222","BK1583","BK1587","BK1574","09997"],"gpt_icon":0},{"id":"2582360713","title":"BRIEF-Venus Medtech Hangzhou Agrees To Sell Property For RMB374.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2582360713","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582360713?lang=en_us&edition=fundamental","pubTime":"2025-11-11 23:18","pubTimestamp":1762874306,"startTime":"0","endTime":"0","summary":"BRIEF-Venus Medtech Hangzhou Agrees To Sell Property For RMB374.6 MlnNov 11 (Reuters) - Venus Medtech Hangzhou Inc 2500.HK:AGREES TO SELL PROPERTY FOR RMB374.6 MILLIONFurther company coverage: 2500.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nFWN3WN0JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02500","BK1100","BK1583","BK1574"],"gpt_icon":0},{"id":"1164058361","title":"VENUS MEDTECH-B (02500) Plans to Sell Hangzhou Property for Approximately RMB375 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1164058361","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164058361?lang=en_us&edition=fundamental","pubTime":"2025-11-11 23:02","pubTimestamp":1762873346,"startTime":"0","endTime":"0","summary":"VENUS MEDTECH-B (02500) announced on November 11, 2025, that the company intends to sell a property (including an industrial park under construction on Plot 1 and Plot 2, along with the associated...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1258","02500","BK1100","BK1229","BK1542","BK1574","BK1583","03913"],"gpt_icon":0},{"id":"2582536360","title":"Venus Medtech Hangzhou - Agrees to Sell Property for RMB374.6 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2582536360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582536360?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:55","pubTimestamp":1762872908,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nFWN3WN0JB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02500","BK1574","BK1100","BK1583"],"gpt_icon":0},{"id":"2582676993","title":"BioDlink International Swings to Nine-Month Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2582676993","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582676993?lang=en_us&edition=fundamental","pubTime":"2025-11-11 22:32","pubTimestamp":1762871522,"startTime":"0","endTime":"0","summary":"BioDlink International  recorded an attributable loss of 3.4 million yuan in the nine months ended Sept. 30, compared with an attributable profit of 35.4 million yuan a year prior, a Tuesday Hong Kong bourse filing said.The biopharmaceutical company's revenue for the three quarters fell 23% to 621.7 million yuan from 809 million yuan in the year-ago period.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","01875","BK1161"],"gpt_icon":0},{"id":"1100166005","title":"Pharma Giant AstraZeneca Hits Record High, Cementing Top Spot in UK Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1100166005","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100166005?lang=en_us&edition=fundamental","pubTime":"2025-11-11 21:52","pubTimestamp":1762869138,"startTime":"0","endTime":"0","summary":"On November 11, shares of pharmaceutical giant AstraZeneca PLC (AZN) rose 2.5% intraday to £134.6, setting a new all-time high. With its market capitalization nearing £210 billion ($282 billion), the...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1574","LU2456880835.USD","LU2236285917.USD","BK4568","LU0320765992.SGD","LU1829250122.USD","LU0889565916.HKD","BK4007","09939","LU2417539215.USD","BK1161","BK4585","LU0109394709.USD","LU2462157665.USD","159938","BK1515","AZN"],"gpt_icon":0},{"id":"1195850925","title":"CARSGEN-B (02171) Repurchases 245,000 Shares for HK$4.047 Million on November 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1195850925","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195850925?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:18","pubTimestamp":1762863501,"startTime":"0","endTime":"0","summary":"CARSGEN-B (02171) announced that it repurchased 245,000 shares for HK$4.047 million on November 11, 2025.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1587","02171","BK1574","BK1585"],"gpt_icon":0},{"id":"1160217558","title":"CSPC Pharma's HER2 Antibody Application Accepted, CR Sanjiu Secures Rare Disease Drug, Domestic CAR-T Goes Global for Over $860M","url":"https://stock-news.laohu8.com/highlight/detail?id=1160217558","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160217558?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:01","pubTimestamp":1762862481,"startTime":"0","endTime":"0","summary":"CSPC Pharma's Pertuzumab Application Accepted   On November 11, the CDE website showed that CSPC Pharma's pertuzumab injection application for HER2-positive breast cancer treatment was accepted....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1008478684.HKD","LU1951186391.HKD","SG9999004220.SGD","BK0175","LU1152091754.HKD","LU1226287529.USD","IE00B031HY20.USD","LU1152091168.USD","BK4022","IE00BZ08YR35.GBP","IE0008369823.USD","IE00B5MMRT66.SGD","IE00BZ08YT58.USD","LU1328277881.USD","LU1226287875.USD","BK4230","BK0012","BK1161","LU1807302812.USD","BK0188","LU1960683339.HKD","LU0326950275.SGD","LU1993786604.SGD","LU0314109678.HKD","LU0315179316.USD","BK1515","06978","LU0140636845.USD","LU1226288253.USD","IE00BZ08YS42.EUR","LU0067412154.USD","IE0008368742.USD","BK0028","BK0239","BK0010","000999","LU0880133367.SGD","LU1226288170.HKD","BK1191","01093","HK0000165453.HKD","LU2039709279.SGD","LU1813983027.USD","BK1574","IE00B543WZ88.USD","CAR","LU0501845795.SGD","BK0060","159992","BK0185","LU0072913022.USD","BK0183","LU1226287792.SGD","BK1521","BK0196"],"gpt_icon":0},{"id":"1152858976","title":"HBM HOLDINGS-B (02142) Repurchases 150,000 Shares for HK$1.978 Million on November 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1152858976","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152858976?lang=en_us&edition=fundamental","pubTime":"2025-11-11 20:00","pubTimestamp":1762862420,"startTime":"0","endTime":"0","summary":"HBM HOLDINGS-B (02142) announced that it repurchased 150,000 shares for HK$1.978 million on November 11, 2025.","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1583","BK1574","BK1161"],"gpt_icon":0},{"id":"2582365583","title":"HBM Holdings Files HKEX Disclosure on Buyback of 150,000 Shares at HKD 13.27 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2582365583","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582365583?lang=en_us&edition=fundamental","pubTime":"2025-11-11 19:56","pubTimestamp":1762862163,"startTime":"0","endTime":"0","summary":"HBM Holdings Ltd. has filed a Next Day Disclosure Return with the Hong Kong Stock Exchange, reporting the repurchase of 150,000 shares at an aggregate price of HKD 1,978,020. The repurchased shares will be held as treasury shares.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HBM Holdings Ltd. published the original content used to generate this news brief on November 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL2LcjRy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02142","BK1161","BK1583","BK1574"],"gpt_icon":0},{"id":"1138130320","title":"Audit Storm Hits Public Hospitals: Irregularities in Procurement and Operations Exposed","url":"https://stock-news.laohu8.com/highlight/detail?id=1138130320","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138130320?lang=en_us&edition=fundamental","pubTime":"2025-11-11 19:51","pubTimestamp":1762861886,"startTime":"0","endTime":"0","summary":"Multiple public hospitals have come under scrutiny for violations such as irregular procurement, unpaid debts, and tied sales, as audit reports reveal widespread issues across the country. **1. Audit...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1222","BK1583","BK1574","09996","09997","BK1100"],"gpt_icon":0},{"id":"1113400322","title":"Non-Executive Director Guo Huaqing Increases Stake in CARSGEN-B (02171) by 30,000 Shares at HK$16.4 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=1113400322","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1113400322?lang=en_us&edition=fundamental","pubTime":"2025-11-11 19:20","pubTimestamp":1762860011,"startTime":"0","endTime":"0","summary":"Latest data from the Hong Kong Stock Exchange shows that on November 10, non-executive director Guo Huaqing purchased an additional 30,000 shares of CARSGEN-B (02171) at HK$16.4 per share, totaling...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1585","02171","BK1574","BK1587","BK1161"],"gpt_icon":0},{"id":"1106342164","title":"BIODLINK-B (01875) Reports Revenue of RMB622 Million in First Three Quarters","url":"https://stock-news.laohu8.com/highlight/detail?id=1106342164","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106342164?lang=en_us&edition=fundamental","pubTime":"2025-11-11 18:34","pubTimestamp":1762857252,"startTime":"0","endTime":"0","summary":"BIODLINK-B (01875) announced that for the nine-month period ended September 30, 2025, the group's revenue reached RMB622 million. However, the company recorded a net loss attributable to equity holders of RMB3.371 million during the same period.","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","01875"],"gpt_icon":0},{"id":"1182236029","title":"JACOBIO-B (01167) Repurchases 72,000 Shares for HK$482,300 on November 11","url":"https://stock-news.laohu8.com/highlight/detail?id=1182236029","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182236029?lang=en_us&edition=fundamental","pubTime":"2025-11-11 18:32","pubTimestamp":1762857128,"startTime":"0","endTime":"0","summary":"JACOBIO-B (01167) announced that on November 11, 2025, the company repurchased 72,000 shares at a price range of HK$6.69 to HK$6.72 per share, totaling HK$482,300.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","01167"],"gpt_icon":0},{"id":"2582350596","title":"Jacobio Pharmaceuticals Repurchases 72,000 Shares at HK$6.70 Each, Files Disclosure Return to HKEX","url":"https://stock-news.laohu8.com/highlight/detail?id=2582350596","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582350596?lang=en_us&edition=fundamental","pubTime":"2025-11-11 18:31","pubTimestamp":1762857099,"startTime":"0","endTime":"0","summary":"Jacobio Pharmaceuticals Group Co. Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, reporting the repurchase of 72,000 shares at a price of HKD 6.698708 per share.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jacobio Pharmaceuticals Group Co. Ltd. published the original content used to generate this news brief on November 11, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nNDL2ll1Cp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01167","BK1161","BK1574"],"gpt_icon":0},{"id":"2582573813","title":"TOT BIOPHARM International 9M Revenue RMB 621.67 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2582573813","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582573813?lang=en_us&edition=fundamental","pubTime":"2025-11-11 18:03","pubTimestamp":1762855439,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nPLX2D2829:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01875","BK1574"],"gpt_icon":0},{"id":"1110391726","title":"Zai Lab (09688) Grants Stock Options and Restricted Share Units","url":"https://stock-news.laohu8.com/highlight/detail?id=1110391726","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110391726?lang=en_us&edition=fundamental","pubTime":"2025-11-11 17:18","pubTimestamp":1762852694,"startTime":"0","endTime":"0","summary":"Zai Lab (09688) announced that on November 10, 2025 (Eastern Time), the company granted stock options to one grantee, allowing the subscription of a total of 500 American Depositary Shares (ADS), and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","BK4548","BK1588","BK4526","BK1574","BK4585","LU2488822045.USD","ZLAB","BK4139","BK4588","09688","BK1161"],"gpt_icon":0}],"pageSize":20,"totalPage":15,"pageCount":4,"totalSize":289,"code":"91000000","status":"200"}]}}